Cilacar 10mg (Cilnidipine)

Product Overview

Cilacar 10mg, marketed under the brand name Cilnidipine, belongs to the calcium‑channel blocker class of antihypertensive agents. It is manufactured by J. B. Chemicals and Pharmaceuticals Ltd, a company with a longstanding presence in the Indian pharmaceutical market. The product is supplied in a strip containing ten tablets, each delivering a precise 10 mg dose of the active ingredient. Pack size options include 30, 60, or 90 tablets, allowing patients to choose a quantity that matches their treatment duration. Cilacar is indicated for the management of essential hypertension and is often prescribed alongside lifestyle modifications such as diet and exercise.

What is Cilacar 10mg (Cilnidipine)

Cilnidipine is a dihydropyridine derivative that selectively blocks L‑type calcium channels in vascular smooth muscle. By inhibiting calcium influx, the drug promotes vasodilation of peripheral arteries and reduces peripheral resistance. This mechanism leads to a modest but clinically significant decrease in systolic and diastolic blood pressure. Unlike some older calcium‑channel blockers, cilnidipine has a relatively balanced effect on both central and peripheral vessels, which may contribute to a lower incidence of peripheral edema. The compound is classified as a third‑generation dihydropyridine, reflecting its improved pharmacokinetic profile.

Uses and Benefits

The primary therapeutic use of Cilacar 10mg is the reduction of elevated blood pressure in adult patients with primary hypertension. Regular use can help lower the risk of cardiovascular events such as stroke, myocardial infarction, and kidney disease. In clinical practice, physicians often select Cilacar when a once‑daily regimen is desired, because the tablet’s half‑life supports steady plasma concentrations throughout the 24‑hour period. Additionally, the medication is generally well tolerated, with a low likelihood of causing significant metabolic disturbances. Patient education emphasizes the importance of adherence to maintain consistent blood pressure control.

How It Works

After oral administration, Cilacar is rapidly absorbed in the gastrointestinal tract and undergoes hepatic metabolism to produce active metabolites that retain calcium‑channel blocking activity. The unchanged parent compound and its metabolites circulate in the bloodstream, reaching peak plasma levels within two to four hours. The drug’s vasodilatory effect manifests as a reduction in systemic vascular resistance, which translates into lower arterial pressure. Because the medication does not significantly affect heart rate, it is considered suitable for patients who cannot tolerate beta‑blockers or other heart‑rate‑modulating agents.

Dosage Guidelines

The recommended starting dose for most adults is one 10 mg tablet taken once daily, preferably at the same time each day to maintain steady drug levels. If blood pressure remains inadequately controlled, a healthcare provider may consider a dose adjustment, but any increase should be done under medical supervision. Patients are advised to swallow the tablet whole with water and to avoid crushing or chewing it, as this could alter the drug’s release characteristics. Consistency in timing helps to prevent fluctuations in blood pressure and supports the long‑term efficacy of therapy.

Side Effects

Like all pharmaceuticals, Cilacar may produce adverse effects, although most are mild and transient. Commonly reported symptoms include headache, dizziness, flushing, and occasional swelling of the ankles. In rare cases, patients may experience more serious reactions such as rapid heartbeat, severe skin rash, or signs of liver dysfunction, including yellowing of the skin or dark urine. If any of these symptoms persist or worsen, the patient should contact a physician promptly. Monitoring of blood pressure and routine laboratory tests can help detect early signs of complications.

Warnings and Precautions

Before initiating therapy, clinicians should review a patient’s medical history for conditions that may influence drug safety, such as severe hepatic impairment, advanced heart failure, or known hypersensitivity to dihydropyridine derivatives. Cilacar is contraindicated in pregnant or breastfeeding women unless the benefits outweigh potential risks, and it should be used with caution in individuals taking concomitant medications that affect the cytochrome P450 enzyme system. Storage instructions recommend keeping the tablets in a cool, dry place away from direct sunlight, and the product must be kept out of reach of children. For additional authoritative guidance, refer to resources such as the NIH, Drugs.com, or MedlinePlus.

Frequently Asked Questions

1. How should Cilacar be taken? The tablet is taken orally once daily, with or without food, but it is best to take it at the same time each day. Swallow the tablet whole with water; do not crush or chew. If a dose is missed, take it as soon as remembered unless it is close to the time for the next dose, in which case the missed dose should be skipped.
2. Can Cilacar be taken with food? Cilacar can be taken with or without meals. Taking it with a heavy fatty meal may slightly delay absorption, but the overall effect on blood pressure remains comparable. Patients who experience gastrointestinal discomfort may prefer to take the tablet with a light snack.
3. What should I do if I miss a dose? If a dose is missed, the patient should take it as soon as the omission is noticed, provided there is enough time before the next scheduled dose. If it is nearly time for the next dose, the missed dose should be skipped and the regular dosing schedule resumed. Doubling the dose is not recommended.
4. Are there any food or alcohol interactions? There are no specific dietary restrictions, but excessive alcohol consumption may enhance the blood‑pressure‑lowering effect and increase the risk of dizziness. Patients should avoid grapefruit juice, as it can affect the metabolism of some calcium‑channel blockers, although evidence for cilnidipine is limited.
5. How long does it take to see a blood pressure reduction? Clinical studies indicate that a measurable reduction in blood pressure can be observed within one to two weeks of consistent use. Full therapeutic effect may require four to six weeks, especially when the medication is used in combination with other antihypertensives or lifestyle changes.

Related Products

• Cilnidipine 5 mg (Generic)
• Nicardia XL 30 Mg (Nifedipine)
• Cilacar (Cilnidipine)
• Cilacar 5 mg (Cilnidipine)
• Cilacar 20mg (Cilnidipine)
• Cilacar T (Cilnidipine/Telmisartan)
• Arkamin 100 (Clonidine)
• Abel 40 mg (Azilsartan Medoxomil)
• Metrogyl Gel (Metronidazole)
• Metrogyl Tablet (Metronidazole)
• Metrogyl 200mg (Metronidazole)
• Metrogyl 400mg (Metronidazole)